Nebenwirkungen · Zomarist
Zomarist 50 mg/850 mg film-coated tablets Zomarist 50 mg/1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-210481 · Präparat HOS-154523
Adverse reactions reported in patients who received vildagliptin in double-blind clinical trials as monotherapy and add-on therapies are listed below by system organ class and absolute frequency. Frequencies are defined as very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1 000 to <1/100); rare (≥1/10 000 to <1/1 000); very rare (<1/10 000), not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-05T17:36:00Z · SHA-256 6dd842a7717af651a76cb98c459aac61fb2e50cebfa9b433555d63e1a27e92c2 · Passage d8e3ee445f9adf4f38f0a959d86a827bfdd5bcb91d4fdb5338b4204c6e7cf148 · Zeichen 939–1449 im Abschnitt